SCHEMBL6163049

SCHEMBL6163049

N=C(NC1CCc2ccccc21)NC1CCc2ccccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.59
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
SLC18A3 Q16572 1/20 0.51
MAOA P21397 4/20 0.50
MAOB P27338 4/20 0.50
TAS1R3 Q7RTX0 1/20 0.50
TAS1R1 Q7RTX1 1/20 0.50
TAS1R2 Q8TE23 1/20 0.50
BCHE P06276 1/20 0.50
ADRA2B P18089 1/20 0.50
ADRA2C P18825 1/20 0.50
ACHE P22303 1/20 0.50
ADRA1A P35348 1/20 0.50
HTR6 P50406 1/20 0.50
HTT P42858 1/20 0.50
EPHX2 P34913 2/20 0.49
ALDH1A1 P00352 1/20 0.49
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11310918 0.90 PDPK1 (0.53) PDPK1CA1CA2SLC18A3MAOA
SCHEMBL6724993 0.89 HTT (0.63) TAS1R3TAS1R1TAS1R2HTTALDH1A1
SCHEMBL1520715 0.86 PDPK1 (0.56) PDPK1CA1CA2SLC18A3MAOA
SCHEMBL10310232 0.86 PDPK1 (0.56) PDPK1CA1CA2SLC18A3MAOA
SCHEMBL3078821 0.82 PDPK1 (0.56) PDPK1CA1CA2TAS1R3TAS1R1
Hydrochloric Acid SCHEMBL11534954 0.80 PDPK1 (0.50) PDPK1CA1CA2SLC18A3MAOA
SCHEMBL191727 0.80 HTT (0.60) PDPK1CA1CA2TAS1R3TAS1R1
SCHEMBL1567171 0.80 PDPK1 (0.58) PDPK1CA1CA2TAS1R3TAS1R1
SCHEMBL3421659 0.80 HTT (0.60) PDPK1CA1CA2TAS1R3TAS1R1
SCHEMBL191726 0.80 HTT (0.60) PDPK1CA1CA2TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0940139-B1 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers SCION PHARMACEUTICALS INC (US) 2005-02-02 EP disclosed
EP-0584088-B1 SUBSTITUTED GUANIDINES AND DERIVATIVES THEREOF AS MODULATORS OF NEUROTRANSMITTER RELEASE AND NOVEL METHODOLOGY FOR IDENTIFYING NEUROTRANSMITTER RELEASE BLOCKERS CAMBRIDGE NEUROSCIENCE RES (US) 1999-10-27 EP disclosed
EP-0940139-A2 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers CAMBRIDGE NEUROSCIENCE RESEARCH, INC. (US) 1999-09-08 EP disclosed
EP-0584088-A4 SUBSTITUTED GUANIDINES AND DERIVATIVES THEREOF AS MODULATORS OF NEUROTRANSMITTER RELEASE AND NOVEL METHODOLOGY FOR IDENTIFYING NEUROTRANSMITTER RELEASE BLOCKERS. CAMBRIDGE NEUROSCIENCE RES (US) 1995-01-18 EP disclosed
EP-0584088-A1 SUBSTITUTED GUANIDINES AND DERIVATIVES THEREOF AS MODULATORS OF NEUROTRANSMITTER RELEASE AND NOVEL METHODOLOGY FOR IDENTIFYING NEUROTRANSMITTER RELEASE BLOCKERS CAMBRIDGE NEUROSCIENCE RESEARCH, INC. (US) 1994-03-02 EP disclosed
WO-1992014697-A1 SUBSTITUTED GUANIDINES AND DERIVATIVES THEREOF AS MODULATORS OF NEUROTRANSMITTER RELEASE AND NOVEL METHODOLOGY FOR IDENTIFYING NEUROTRANSMITTER RELEASE BLOCKERS CAMBRIDGE NEUROSCIENCE, INC. (US) 1992-09-03 WO disclosed